tiprankstipranks
Advertisement
Advertisement

Tristel Issues New Shares Following Employee Option Exercise

Story Highlights
  • Tristel expands its global infection prevention business using proprietary chlorine dioxide chemistry.
  • The company issued 10,000 new shares via option exercise, lifting voting rights to 47,931,543.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
Tristel Issues New Shares Following Employee Option Exercise

Claim 55% Off TipRanks

Tristel ( (GB:TSTL) ) has issued an update.

Tristel plc, the AIM-listed infection prevention specialist focused on chlorine dioxide-based decontamination products for medical devices and healthcare surfaces, operates globally from its Snailwell, near Cambridge, headquarters. The company supplies hospitals worldwide under the Tristel and Cache brands through 14 subsidiaries across 40 countries.

Tristel has issued 10,000 new ordinary shares following the exercise of employee share options, with admission to trading on AIM expected on 18 February 2026. Following this issue, the company’s share capital will comprise 47,931,543 ordinary shares and voting rights, a figure shareholders can use to assess disclosure obligations under FCA transparency rules.

The most recent analyst rating on (GB:TSTL) stock is a Buy with a £478.00 price target. To see the full list of analyst forecasts on Tristel stock, see the GB:TSTL Stock Forecast page.

Spark’s Take on GB:TSTL Stock

According to Spark, TipRanks’ AI Analyst, GB:TSTL is a Outperform.

Tristel’s strong financial performance and positive earnings call outlook are the primary drivers of its stock score. While technical indicators suggest caution due to overbought conditions, the company’s strategic expansion and dividend increase support a favorable long-term view. Valuation concerns are mitigated by the company’s growth prospects.

To see Spark’s full report on GB:TSTL stock, click here.

More about Tristel

Tristel plc is a global infection prevention company that manufactures and supplies products based on its proprietary chlorine dioxide chemistry. It is a market leader in manual decontamination of medical devices under the Tristel brand and offers sporicidal surface disinfection products under the Cache brand, operating from its Cambridge-area headquarters with 14 subsidiaries selling into 40 countries.

Average Trading Volume: 128,465

Technical Sentiment Signal: Buy

Current Market Cap: £204.3M

For a thorough assessment of TSTL stock, go to TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1